Clinical Trial Update: Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

This entry notes a Phase 2 clinical trial evaluating the efficacy and safety of KPCXM18 Injection in acute ischemic stroke, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• KPCXM18 Injection

Snippet

Sponsor: Kunming Pharmaceuticals, Inc. | Conditions: Acute Ischemic Stroke | Phase 2 | Status: RECRUITING